Actively Recruiting
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
Led by University Hospital, Strasbourg, France · Updated on 2025-08-08
100
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
CONDITIONS
Official Title
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- BK positive
- Adult
- Willing to participate in research
You will not qualify if you...
- Under guardianship
- Under curatorship
- Opposed to research
- Deprived of liberty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de Virologie - CHU Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
A
Anne-Sophie U GEY
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here